Cargando…

p53 Gene (NY-CO-13) Levels in Patients with Chronic Myeloid Leukemia: The Role of Imatinib and Nilotinib

The p53 gene is also known as tumor suppressor p53. The main functions of the p53 gene are an anticancer effect and cellular genomic stability via various pathways including activation of DNA repair, induction of apoptosis, and arresting of cell growth at the G1/S phase. Normally, the p53 gene is in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-kuraishy, Hayder M., Al-Gareeb, Ali I., Al-Buhadilly, Ali K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5871959/ https://www.ncbi.nlm.nih.gov/pubmed/29370077 http://dx.doi.org/10.3390/diseases6010013

Ejemplares similares

Rosuvastatin Improves Vaspin Serum Levels in Obese Patients with Acute Coronary Syndrome
por: Al-kuraishy, Hayder M., et al.
Publicado: (2018)

First-line treatment for chronic myeloid leukemia: dasatinib, nilotinib, or imatinib
por: Wei, Guoqing, et al.
Publicado: (2010)

Successful Nilotinib Treatment in a Child with Chronic Myeloid Leukemia
por: Al-Jafar, Hassan A., et al.
Publicado: (2015)

Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib
por: Swords, Ronan, et al.
Publicado: (2009)

Safety and Efficacy of Elective Switch from Nilotinib to Imatinib in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia
por: Ibrahim, Ali, et al.
Publicado: (2022)

A novel t(3;12)(q21;p13) translocation in a patient with accelerated chronic myeloid leukemia after imatinib and nilotinib therapy
por: Bennour, Ayda, et al.
Publicado: (2013)

Treatment-free remission after discontinuation of imatinib, dasatinib, and nilotinib in patients with chronic myeloid leukemia
por: Han, Jae Joon
Publicado: (2023)

Effects of Rosuvastatin Alone or in Combination with Omega-3 Fatty Acid on Adiponectin Levels and Cardiometabolic Profile
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2016)

The effect of imatinib and nilotinib on blood calcium and blood potassium levels in chronic myeloid leukemia patients: a literature review
por: Prenggono, Muhammad Darwin, et al.
Publicado: (2021)

Nilotinib: a novel encouraging therapeutic option for chronic myeloid leukemia patients with imatinib resistance or intolerance
por: Martinelli, Giovanni, et al.
Publicado: (2007)

Refining targeted therapies in chronic myeloid leukemia: development and application of nilotinib, a step beyond imatinib
por: Breccia, Massimo, et al.
Publicado: (2008)

Long‐term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib
por: Cortes, Jorge E., et al.
Publicado: (2016)

Successful Peripheral Blood Stem Cells Collection in Imatinib Pretreated and Nilotinib-Treated Chronic Myeloid Leukemia Patient
por: Vokurka, Samuel, et al.
Publicado: (2010)

Allografting for Bosutinib, Imatinib, Nilotinib, Dasatinib, and Interferon Resistant Chronic Myeloid Leukemia without ABL Kinase Mutation
por: Uz, B., et al.
Publicado: (2011)

An economic analysis of high-dose imatinib, dasatinib, and nilotinib for imatinib-resistant chronic phase chronic myeloid leukemia in China: A CHEERS-compliant article
por: Wu, Bin, et al.
Publicado: (2017)

Statin therapy associated with decreased neuronal injury measured by serum S100β levels in patients with acute ischemic stroke
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2021)

Potential Effects of Pomegranate on Lipid Peroxidation and Pro-inflammatory Changes in Daunorubicin-induced Cardiotoxicity in Rats
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2016)

Effect of orlistat alone or in combination with Garcinia cambogia on visceral adiposity index in obese patients
por: Al-kuraishy, Hayder M., et al.
Publicado: (2016)

Eustress and Malondialdehyde (MDA): Role of Panax Ginseng: Randomized Placebo Controlled Study
por: Al-kuraishy, Hayder M., et al.
Publicado: (2017)

Effects of rosuvastatin on metabolic profile: Versatility of dose-dependent effect
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2019)

Comparison of deferasirox and deferoxamine effects on iron overload and immunological changes in patients with blood transfusion-dependent β-thalassemia
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2017)

Acylation-stimulating protein is a surrogate biomarker for acute myocardial infarction: Role of statins
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2017)

Central Beneficial Effects of Trimetazidine on Psychomotor Performance in Normal Healthy Volunteers
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2017)

Acute kidney injury and COVID-19
por: Al-kuraishy, Hayder M., et al.
Publicado: (2021)

Citicoline Improves Human Vigilance and Visual Working Memory: The Role of Neuronal Activation and Oxidative Stress
por: Al-kuraishy, Hayder M., et al.
Publicado: (2020)

Statin therapy improves serum Annexin A1 levels in patients with acute coronary syndrome: A case-controlled study
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2021)

Ramadan Fasting in a Patient with Chronic Myeloid Leukemia Receiving Nilotinib as Upfront
por: Al-Dubai, Husam N., et al.
Publicado: (2020)

OCT-1, ABCB1, and ABCG2 Expression in Imatinib-Resistant Chronic Myeloid Leukemia Treated with Dasatinib or Nilotinib
por: Kim, Yeo-Kyeoung, et al.
Publicado: (2014)

Metabolic profile and prolactin serum levels in men with type 2 diabetes mellitus: Old-new rubric
por: Al-Nami, Marwa S., et al.
Publicado: (2019)

Development and targeted use of nilotinib in chronic myeloid leukemia
por: Fava, Carmen, et al.
Publicado: (2009)

Assessment of serum prolactin levels in acute myocardial infarction: The role of pharmacotherapy
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2016)

Metformin enhances the cytotoxic effect of nilotinib and overcomes nilotinib resistance in chronic myeloid leukemia cells
por: Na, Yoo Jin, et al.
Publicado: (2021)

The relative efficacy of imatinib, dasatinib and nilotinib for newly diagnosed chronic myeloid leukemia: a systematic review and network meta-analysis
por: Mealing, Stuart, et al.
Publicado: (2013)

Experience using Imatinib and then Nilotinib, as second line, in patient with chronic myeloid leukemia and previous bariatric surgery. A case report
por: Centrone, Renato, et al.
Publicado: (2020)

Rosuvastatin as forthcoming antibiotic or as adjuvant additive agent: In vitro novel antibacterial study
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2018)

Vinpocetine Improves Oxidative Stress and Pro-Inflammatory Mediators in Acute Kidney Injury
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2019)

Renoprotective effect of irbesartan in a rat model of gentamicin-induced nephrotoxicity: Role of oxidative stress
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2019)

Irbesartan Attenuates Gentamicin-induced Nephrotoxicity in Rats through Modulation of Oxidative Stress and Endogenous Antioxidant Capacity
por: Al-kuraishy, Hayder M., et al.
Publicado: (2020)

Impact of thioctic acid on glycemic indices and associated inflammatory-induced endothelial dysfunction in patients with type 2 diabetes mellitus: A case control study
por: Al-Nami, Marwa S., et al.
Publicado: (2020)

Differential effect of metformin and/or glyburide on apelin serum levels in patients with type 2 diabetes mellitus: Concepts and clinical practice
por: Al-Kuraishy, Hayder M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ie6m368rr19fqqiab5f3dkq64p